Latest Organon News & Updates

See the latest news and media coverage for Organon. We track all announcements, press releases, and industry mentions in real time, all in one place.

Organon

Global healthcare company focused on women's health

organon.com

Headquarters: Jersey City, United States
Company type: Public company
Number of employees: 10,000+
Industry: Pharmaceuticals

Last updated Yesterday

Latest news about Organon

In short: Organon agreed to a $11.75 billion Sun Pharma takeover while advancing MIUDELLA and biosimilars.

Company announcements

October 16 Organon

Organon shares positive MIUDELLA phase 3 results

Interim data confirms safety through six years, and the FDA accepted a supplemental application for extended use, targeting Q2 2027 approval.

September 14 Organon

Organon announces FDA acceptance of MIUDELLA review

The FDA accepted a supplemental application to extend the approved use of this hormone-free copper IUD from three years to six years.

August 4 Organon

Organon mandates NEXPLANON REMS certification by August 23, 2026

All healthcare providers who dispense or administer NEXPLANON must become certified, including previous Clinical Training Program completers, to mitigate complications from improper insertion and removal.

July 24 Organon

Organon presents new data for VTAMA cream in atopic dermatitis

Pooled Phase 3 data showed early, consistent improvements across pediatric age groups and adults, as early as week 2.

Media coverage

Yesterday MarketScreener

Organon & Co. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026

Organon & Co. is a global healthcare company. The Company is engaged in developing and delivering health solutions through a portfolio of prescription therapies and...

October 20 MLex

Sun Pharma's bid for Organon under review in Australia | MLex | Specialist news and analysis on legal risk and regulation

MLex Summary: India-based pharmaceutical company Sun Pharma’s proposed acquisition of US-based Organon is under review by Australia's competition watchdog. The Australian Competition & Consumer Commission...

October 19 Finanztrends

Organon Stock: No more earnings conference call

Organon cancels earnings calls due to pending acquisition; MIUDELLA shows positive study data, FDA review continues.

October 10 Whalesbook

Indian Pharma Giants Push for Innovation Amid Sun Pharma’s $11.75B Acquisition

Indian pharma leaders urge a shift from generics to innovation. Explore the strategy behind Sun Pharma's $11.75B Organon deal ...

Never miss news about Organon

Track Organon and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Organon competitors & trending companies

Browse news for competitors to Organon and other trending companies.